Data Science ad Machine Learning in treatment planning- GU and GI cancers, DS/ML learning problems, AI segmentation, automated treatment planning, clinical challenges,

Locally advance prostate cancer, Ca prostate, RT dose escalation, IGRT, spacers, SBRT

Prostate cancer overview, androgen axis, ADT for prostate, Adverse effects, ADT timing, prostate management,

Anal cancer treatment and IMRT, RT dose fractionation, IMRT treatment fields and dose criteria, helical tomotherapy, toxicity, outcomes

active surveillance in prostate cancer, exclusion criteria, surgery vs. radiotherapy criteria for prostate cancer, active surveillance guidelines, risk stratifications, radical treatment

SBRT in high risk prostate cancer, patient selection for SBRT, carcinoma prostate, treatment with a pacemaker, treatment planning, contouring guidelines, CT-MRI fusion,

IGRT for Prostate Cancer, patient positioning, hydrogel spacers, image interpretation, Ultrasound use, PTV margins and imaging modality, action limits,

Muscle invasive bladder cancer, radiation, imaging for bladder cancer, full bladder vs. empty bladder, partial bladder treatment, dose fractionation, recurrent cancer,

Ca Prostate, role of adjuvant ADT,

IMRT, patient setup for IMRT in prostate cancer, Axial T2 MRI, risk of SV involvement, target volumes, dose and fractionation, salvage vs. adjuvant RT

Clinical node positive prostate cancer, postop PET scan, androgen deprivation therapy, ADT +/- RTIN N1 prostate cancer, STAMPEDE, survival outcomes

Adjuvant vs Savage, PORT, RADICALS-RT Trial, PSA, ADT use to delay time to progression, CAPRA-S, Early Salvage, Timing of radiaotherapy after prostatectomy, CAPRA score

prostate brachytherapy, dose rate, LDR, HDR, monotherapy, external beam therapy, iodine-125, I125, stranded seeds, Mick applicator

adjuvant radiotherapy, bladder cancer, RT, simulation contouring, diabetic mellitus, urothelial carcinoma, CECT TAP, MIBC, LR failure, LR Rx, LRF, RCIC, Locoregional failure, local-regional, cystectomy, risk grouping, IMRT contouring, pelvis, BART Trial, RCTs, CTVp, CTVn, planning parameters, int...

brachytherapy, prostate cancer, monotherapy, EBRT, hypofractionation, SBRT, side effects, QOL, quality of life, IPSS, meta-analysis, HDR, LDR, urinary adverse events, ASCENDE-RT, DE-EBRT, LDR-PB, FLAME, toxicity profile, IMRT, SHORT, Gy, HR prostate cancer, risk groups, cell survival, radiation d...

contouring nuances, OAR, prostate cancer radiotherapy, risk stratification, PSA level, intensity-modulated radiotherapy versus stereotactic body radiotherapy, SBRT, moderate hypofractionation, nodal coverage, RTOG pelvis, IMRT, rectum, define post boundary of prostate, anatomy of LA, PR, PC, IC, ...